Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Preliminary ProgramFull Access

Preliminary Program: Saturday, May 14

Published Online:18 Feb 2011https://doi.org/10.1176/pn.46.4.psychnews_46_4_12_1

7 a.m.-8:30 a.m.

Scientific and Clinical Reports

SCR1. Anxiety Disorders

  • Long-Term and Withdrawal Phase of Treatment of Panic Disorder With Clonazepam or Paroxetine: A Randomized, Naturalistic Study Antonio Nardi, M.D.

  • A Longitudinal Investigation of the Role of Self-Medication in the Development of Comorbid Anxiety and Substance Use Disorders Jennifer Robinson, M.A.

  • Predictors of Treatment Response in Canadian Combat and Peacekeeping Veterans With Military-Related PTSD J. Don Richardson, M.D.

  • The Abnormalities of Myelin Integrity in Obsessive-Compulsive Disorder: A Multi-Parameter Diffusion Tensor Imaging Study Qing Fan, M.D.

SCR2. Biological Psychiatry and Neuroscience

  • 5. Postmortem Dopamine Abnormalities in Human Cocaine Users: New Targets for In Vivo Imaging and Therapeutic Interventions Karley Little, M.D.

  • 6. Integrating Neuroscience Advances Into Clinical Psychiatric Practice David Hellerstein, M.D.

  • 7. Neurological Underpinnings of Food Intake, Energy Balance, and Obesity: Implications for Psychiatrists Treating Patients With Atypical Antipsychotics Sandhya Narayanan, M.A.

SCR3. Child and Adolescent Psychiatry

  • 8. Psychodynamic Profile of Diabetic Adolescent Patients Hani Hamed Dessoki, M.D.

  • 9. Comparison of Face Recognition in Non-Affected Siblings of Autistic Children and Normal Group Zahra Shahrivar, M.D.

  • 10. Cortical Thickness Correlates of Attention Problems in a Large-Scale Representative Cohort of 4- to 18-Year-Old Healthy Children Without ADHD Simon Ducharme, M.D.

  • 11. Genetic Evidence in Autism: A Review of the Literature Felicia Iftene, M.D., Ph.D.

Workshops

W1. Supervision: The Slippery Slope: Teacher? Mentor? Police? Therapist?Chair: Yener Balan, M.D.

W2. Recognition, Diagnosis, and Treatment of the Workplace Mobbing VictimChair: James R. Hillard, M.D.

W3. Pan-Pacific Perspectives on Asians/Pacific Islanders, Substance Abuse, and Their TreatmentChair: John W. Tsuang, M.D.

W4. Applications and Lessons Learned From the HIV Psychiatry Liaison Experience for General PsychiatristsChair: Philip A. Bialer, M.D.

W5. Maintenance of Certification: Lessons From the TrenchesChair: Annette M. Matthews, M.D.

W6. Helping Patients Who Drink Too Much: Using the NIAAA Clinician's GuideChairs: Robert Huebner, M.D., Mark Willenbring, M.D.

7 a.m.-11 a.m.

Course 1

Seminar

SM2. Seeing the Forest and the

Trees: An Approach to Biopsychosocial FormulationChair: William H. Campbell, M.D., M.B.A.

7 a.m.-2 p.m.

Courses 2-4

Master Course

MC01. Update on Pediatric PsychopharmacologyChair: Christopher Kratochvil, M.D.

Seminar

SM1. International Medical GraduatesChair: Jacob Sperber, M.D.

8 a.m.-9 a.m.

Lectures

L1. The Doctor I Need for the Health Care I WantChair: Darrell G. Kirch, M.D.

L2. Rethinking Mental IllnessChair: Thomas Insel, M.D.

8 a.m.-11 a.m.

Advances in Medicine

AM1. Medical Mysteries and Practical Medical Psychiatric Updates: Is it "Medical," "Psychiatric," or a Little of Both...?Chair: Robert M. McCarron, D.O.

Media Workshop

MW1. Cluster B Personality Disorders and the Neo-Noir Femme FataleChair: Scott Snyder, M.D.

Symposia

S1. Scope, Current Evidence, and Innovative Approaches in Managing PTSD in the MilitaryAmerican Psychiatric Institute for Research and Education

  • Epidemiology and Treatment of Posttraumatic Stress Disorder Associated With Combat: A Critical Look at the Evidence Charles Hoge, M.D.

  • Pharmacotherapy for Posttraumatic Stress Disorder David Benedek, M.D.

  • Understanding the Evidence on Evidence-Based Psychotherapy for Posttraumatic Stress Disorder Paula Schnurr, Ph.D.

  • Mental Health Services Delivery in Primary Care Edward Post, M.D.

  • Re-engineering Systems of Primary Care Treatment for Posttraumatic Stress Disorder and Depression in the U.S. Military: Program Description and Implementation Charles Engel, M.D., M.P.H.

  • DoD/APIRE Posttraumatic Stress Disorder Care Dissemination Project Update Farifteh Duffy, Ph.D.

S2. Therapeutic and Research Implications of Dissociation in PTSD: A Gap in Our Awareness?

  • Historical Overview of Traumatic Dissociation in Psychotraumatology Eric Vermetten, M.D., Ph.D.

  • The Diagnostic Domain of Dissociative Symptoms: Assessment in the Context of a Dissociative Subtype of PTSD Richard Loewenstein, M.D.

  • The Theoretical and Statistical Differentiation of Fantasy and Trauma Models of Dissociation Constance Dalenberg, Ph.D.

  • Emotion Dysregulation in PTSD: Evidence for a Dissociative Subtype Lanius Ruth, M.D., Ph.D.

  • Dissociation in DSM-5 ASD and PTSD David Spiegel, M.D.

S3. Understanding the Risk of Suicide Associated With Recent Discharge

  • Prospective Risk Factors for Suicide Ideation and Behavior in Recently Discharged Patients Paul Links, M.D.

  • Understanding the Risks of Recent Discharge: The Phenomenological Lived Experiences John Cutcliffe, Ph.D., B.Sc.

  • Is Research With Suicidal Participants Risky Business? Jesmin Antony, M.S.

  • Suicide Risk Associated With Recent Discharge: Moving From Models to Intervention Ken Balderson, M.D., B.Sc.

S4. Brain Mechanisms and Neuropsychiatry in Smoking Cessation

  • Brain Functional Magnetic Resonance Imaging (fMRI) Reactivity and Attentional Bias in Tobacco Abstinence Amy Janes, Ph.D.

  • Impulsivity in Smoking Cessation Richard Yi, Ph.D.

  • Naltrexone in Supplementing Nicotine Replacement Therapy for Smokers Benjamin Toll, Ph.D.

  • Behavioral Activation in Depressed Smokers Receiving Nicotine Replacement Therapy Laura MacPherson, Ph.D.

9 a.m.-10:30 a.m.

Scientific and Clinical Reports

SCR4. Cognitive Disorders (Delirium, Dementia)

  • 12. Comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental Status Exam (MMSE) in Identifying Cognitive Deficits in Mood Disorders Neha Jain, M.D.

  • 13. Epidemiological Survey of Influences of Long-Term Treatment With a Traditional Japanese Medicine, Yokukansan, on Behavioral and Psychological Symptoms Kazunori Okahara, M.D.

  • 14. Addressing Patients Needs I: Feelings of Loneliness but Not Social Isolation Predict Incident Dementia in Older Persons Tjalling Holwerda, M.D.

  • 15. The Montreal Cognitive Assessment (MoCA): Why to Use it, How to Use it, and How to Score it Sandra Jacobson, M.D.

SCR5. Cross-Cultural and Minority Issues

  • 16. Traditional and Alternative Healers: Prevalence of Use in Psychiatric Patients Zukiswa Zingela, M.B.B.S., M.Med.

  • 17. Investigating a Decade of Psychiatric Research in the Arab Gulf Region Ossama Osman, M.D., M.B.A.

  • 18. A Follow-Up Study of Risk and Protective Factors Influencing Posttraumatic Stress Reactions in Sierra Leonean Former Child Soldiers Theresa Betancourt, Sc.D., M.A.

  • 19. Motives for Khat Use and Abstinence in Yemen: A Gender Perspective Felix Wedegaertner, M.D., M.P.H.

SCR6. Epidemiology

  • 20. Psychiatric Comorbidity and Suicidal Ideation Associated With PTSD in the Baseline Sample of 2,616 Soldiers in the Ohio Army National Guard Joseph Calabrese, M.D.

  • 21. Underrecognition and Undertreatment of Depressed Chinese Americans in Primary Care Albert Yeung, M.D., Sc.D.

  • 22. Association Among Traumatic Experiences With Physical Health Conditions in a Nationally Representative Sample M. Natalie Husarewycz, M.D.

  • 24. Sex Differences in Work Stress in a Representative Sample of the Canadian Forces Natalie Mota, M.A.

Workshops

W7. Children of PsychiatristsChairs: Michelle B. Riba, M.D., M.S., Leah J. Dickstein, M.D., M.A.

W8. Introduction to the Evaluation of the Pain PatientChairs: Manu Mathews, M.D., Ed C. Covington, M.D.

W9. Electronic Health Records: Taking the PlungeAPA Committee on Electronic Health Records; Chairs: Robert M. Plovnick, M.D., M.S., Laura J. Fochtmann, M.D.

W10. The Tumultuous Marriage of Psychiatry and Religion and the Birth of the Biopsychosociospiritual FormulationAPA/SAMHSA Minority Fellows; Chairs: Amelia K. Villagomez, M.D., Billina R. Shaw, M.D.

W11. The New York State OMH SHAPEMEDs Project: Creating and Implementing an Antipsychotic Prescribing Care Pathway Via Public-Academic PartnershipChairs: Sharat Parameswaran, M.D., Matthew Erlich, M.D.

W12. Mood and Menopause: A Closer Look Into Diagnostic and Treatment PerspectivesChair: Claudio N. Soares, M.D., Ph.D.

10 a.m.-11:30 a.m.

Lectures

L3. American Exceptionalism and National Identity: Can We All Just Grow Up?Chair: Brig. Gen. Loree Sutton (Ret.)

L4. Benjamin Rush LectureChair: Andrea Tone, M.D.

New Research Resident Poster Session 1

11 a.m.-12:30 p.m.

Scientific and Clinical Reports

SCR7. Forensic Psychiatry

  • 24. Ethical and Clinical Aspects of Pre-Trial Forced Nasogastric Administration of Medication William Richie, M.D.

  • 25. AMA VI Psychiatric Impairment Assessment: Is It Valid? Gordon Davies, M.B., D.P.M.

  • 26. Women, Malingering, and the SIRS: Gender Differences in the Structured Interview of Reported Symptoms Jessica Ferranti, M.D.

SCR8. Schizophrenia and Other Psychotic Disorders 1

  • 27. Affective Deficits in Schizophrenia Revisited: The Role of Ambivalence and Alexithymia Fabien Tremeau, M.D.

  • 28. Current Prescribing Practices: Antidepressant Use in Schizophrenia Megan Ehret, Pharm.D.

  • 29. Does Social Support Prevent Relapse and Rehospitalization in Early-Onset Schizophrenia? Results From the Lambeth Early-Onset Study Raymond Tempier, M.D., M.Sc.

SCR9. Health Services Research

  • 30. Cancer Treatment for People With Mental Illness: A Systematic Review of the Literature Simha Ravven, M.D.

  • 31. Partial Hospitalization Program (PHP) for Adults in Psychiatric Distress: Predictors and Characteristics of Clinical Response Deshmukh Parikshit, M.D.

  • 32. Impact of a Comprehensive Crisis Response Team on Utilization of Hospital and Emergency Services Deepika Sabnis, M.D.

  • 33. Two Implementation Models for Integration of Physical Health Into a Behavioral Health Setting for Patients With Severe and Persistent Mental Illness Shula Minsky, Ed.D.

Workshops

W13. Emergency Psychiatry: A Global PerspectiveAmerican Association for Emergency Psychiatry; Chairs: Rachel L. Glick, M.D., Julien J.C. de Carvalho, M.D.

W14. American Board of Psychiatry and Neurology Update: Certification in Psychiatry and Its SubspecialtiesChairs: Larry R. Faulkner, M.D., Victor I. Reus, M.D.

W15. Promises and Problems in Compensation and Pension Examinations for VeteransChair: Jagannathan Srinivasaraghavan, M.D.

W16. Caring for the Caregiver: The "Hidden" PatientChair: Amita R. Patel, M.D.

W17. Presurgical Psychiatric Evaluation of Patients Seeking Bariatric SurgeryChair: Zubeida Z. Mahomedy, M.D., M.Med.

W18. Polypharmacy in Schizophrenia: To Be or Not to Be!Chairs: Durga Bestha, M.B.B.S., Vishal Madaan, M.D.

Noon-1:30 p.m.

Lecture

L5. John Fryer Award LectureChair: The Right Rev. B. Gene Robinson

Noon-3 p.m.

Media Workshop

MW2. Faith and Resilience: Carl Dreyer's "The Passion of Joan of Arc"Chair: Francis Lu, M.D.

Presidential Symposium

PS1. Teaching Psychodynamic Psychiatry in the Era of NeuroscienceChair: Carol C. Nadelson, M.D.; Discussant: Carol A. Bernstein, M.D.

  • Psychotherapy Teaching Strategies Glen O. Gabbard, M.D.

  • Management Versus Interpretation: Teaching Psychotherapy to Residents Edward Shapiro, M.D.

  • Teaching Psychodynamic Psychotherapy: Programs in Boston and Cleveland Malkah Notman, M.D.

  • Teaching Psychodynamic Psychotherapy: Programs in Boston and Cleveland Norman Clemens, M.D.

  • Learning Psychotherapy: The Experience of Psychiatry Residents Michael Ferri, M.D.

Symposia

S5. Choosing the Right Treatment for Substance Abuse

  • Choosing the Right Treatment for Cocaine Dependence Adam Bisaga, M.D.

  • Choosing Treatment for Cannabis Dependence Frances Levin, M.D.

  • Combining Medications and Psychosocial Interventions in the Treatment of Substance Abuse Edward Nunes, M.D.

  • Opioid Dependence: A gonist and Antagonist Treatment Options for Addiction Maria Sullivan, M.D., Ph.D.

  • Detecting and Managing Sedative-Hypnotic and Stimulant Abuse John Mariani, M.D.

S6. Health Care Reform and Mental Health Care FinancingNational Institute of Mental Health

  • Impact of Medicaid Prescription Cost-Containment Policies on Antipsychotic Medication Use Among Schizophrenia Patients Jalpa Doshi, Ph.D.

  • Medicare Part D Coverage Gap and Mental Health Yuting Zhang, Ph.D., M.S.

  • Measuring Quality Adjusted Life Years for Economic Evaluations of Treatment Services for Children With Autism J. Mick Tilford, Ph.D.

  • Reducing Disparities in Mental Health Expenditures Among Children in Child Welfare Ramesh Raghavan, M.D., Ph.D.

  • Reducing Disparities in Mental Health Expenditures Among Children in Child Welfare Derek Brown, Ph.D.

S7. Pediatric Bipolar Disorder: Advances and Challenges in Diagnosis, Biomarkers, and Treatment ModalitiesAPA Council on Children, Adolescents, and Their Families; Chair: Erin C. Soto, M.D.

  • An Evidence-Based Approach to Careful Assessment and Accurate Assessment of Bipolar Disorder in Children and Adolescents Cathryn Galanter, M.D.

  • Prodromal Bipolar Disorder in Youth: Diagnosis and Early Intervention Kiki Chang, M.D.

  • Neurobiomarkers of Adolescent Bipolar Disorder Melissa DelBello, M.D.

  • Evidence-Based Treatments for Pediatric Bipolar Disorder Erin Soto, M.D.

S8. Mood Disorders Across the Lifespan: Implications forDSM-5 American Psychiatric Institute for Research and Education

  • Mood Disorders Across the Lifespan: Implications for DSM-5 David Shaffer, M.D.

  • Young Adulthood: Prime Time for Onset of Bipolar Disorder Ellen Frank, Ph.D.

  • Adult Major Depressive Disorder and the Bereavement Exclusion Sidney Zisook, M.D.

  • The Prognostic Importance of Anxiety Symptoms in Unipolar and Bipolar Depressive Episodes William Coryell, M.D.

  • The Origins and Presentation of Depression in Later Life: A Review Dan Blazer, M.D., Ph.D.

1 p.m.-2:30 p.m.

Forum

F1. Kaho'olawe: Healing a Violently Traumatized CultureChair: Naleen Andrade, M.D.

Scientific and Clinical Reports

SCR10. Mood Disorders 1

  • 34. Study Design Features Affecting Outcome in Antidepressant Trials Florian Seemüller, M.D.

  • 35. Addressing Patients' Needs III: Community Mental Health Care for Nonpsychotic Chronic Patients Tjalling Holwerda, M.D.

  • 36. Large-Scale Depression Screening in Primary Care—Unexpected Benefits Gabrielle Beaubrun, M.D.

Workshops

W19. The Kaona of HulaChair: Nanette H. Orman, M.D.

W20. Stress Management for Resilient Women in Psychiatry: In Tribute to Tana Weliky-GradyAssociation of Women Psychiatrists; Chair Mary Kay Smith, M.D.

W21. Growing Up in APA: A Case Study on Mentorship

W22. Multiple Perspectives on Overcoming Challenges to CBT Training for Psychiatry ResidentsChairs: Vicki Gluhoski, Ph.D., Hulya M. Erhan, Ph.D.

W23. All in the Gay Family—Lesbian and Gay Families: Past, Present, and FutureChair: Kenn Ashley, M.D.

W24. Psychiatric Symptoms in Patients With Parkinson's DiseaseChairs: Mateusz Zurowski, M.D., M.S., Andrew Howard, M.D.

W25. Translating Expert Opinion Into Strong Recommendations: New APA Practice Guidelines on Psychiatric ManagementAPA Steering Committee on Practice Guidelines; Chair: Joel Yager, M.D.

W26. Collaborating With Primary Care in the Disaster Setting: Clinical Issues for PsychiatristsChairs: Catherine S. May, M.D., Elspeth C. Ritchie, M.D., M.P.H.

W27. Treatment Challenges in Schizophrenia With Comorbid Conditions: Tailored ManagementChairs: Michael Y. Hwang, M.D., B.S., Henry A. Nasrallah, M.D.

W28. Movement Disorders in Psychiatry: A Video WorkshopChairs: Peter N. Van Harten, M.D., Ph.D., Hans W. Hoek, M.D., Ph.D.

1 p.m.-3 p.m.

New Research Resident Poster Session 2